Physician profile
Ding C Yang
NPI 1417127705
$6,950.80
in general payments reported to CMS, 2019-2025
14 companies · $779 in 2025
The $779 reported for 2025 was more than what 75% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,360 · 2020: $179 · 2021: $435 · 2022: $1,021 · 2023: $309 · 2024: $869 · 2025: $779.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,768 · Travel and Lodging: $188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,768.19 |
| Travel and Lodging | $187.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elite Orthopedics, LLC | $3,157.00 | 2019 | |
| Advanced Oxygen Therapy INC. | $1,042.28 | 2021-2025 | Topical Oxygen Chamber For Extremities, Topical Oxygen Chamber For Extremities |
| Acumed LLC | $491.40 | 2022-2025 | Osteomed, Acumed, Acumed |
| Ibsa Pharma INC. | $463.72 | 2021-2024 | Tirosint, Tirosint, Licart |
| Kerecis Limited | $321.85 | 2022-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Smith+Nephew, INC. | $305.05 | 2019-2022 | |
| Stryker Corporation | $296.37 | 2022-2025 | Citrefix, Graftjacket, Allowrap |
| Paragon 28, INC. | $203.46 | 2021-2022 | |
| Organogenesis INC. | $203.41 | 2019-2022 | |
| Medshape, INC. | $187.97 | 2024 | Dynanail |
| Royal Biologics, INC. | $148.92 | 2021 | |
| Medtronic Vascular, INC. | $90.86 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $20.19 | 2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $18.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ding Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.